4.74
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
CHART Trader
Monthly Subscription
for only
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Stereotaxis Inc | STXS | AMEX | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
0.00 | 0.0% | 4.74 | 07:00:55 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.74 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
1 | 20 | 209,446 | 1.70 - 5.58 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
07:55:20 | 20 | $ 4.69 | USD |
Stereotaxis Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 349.27M | 73.69M | 39.33M | $ 28.90M | $ -7.98M | -0.10 | -41.60 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
Stereotaxis News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STXS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.99 | 5.09 | 4.65 | 4.89 | 114,456 | -0.25 | -5.01% |
1 Month | 5.09 | 5.43 | 4.56 | 5.01 | 159,641 | -0.35 | -6.88% |
3 Months | 3.32 | 5.43 | 3.03 | 4.62 | 183,053 | 1.42 | 42.77% |
6 Months | 3.84 | 5.43 | 3.03 | 4.13 | 179,411 | 0.90 | 23.44% |
1 Year | 5.37 | 5.58 | 1.70 | 4.10 | 251,956 | -0.63 | -11.73% |
3 Years | 3.06 | 5.82 | 1.70 | 4.20 | 240,854 | 1.68 | 54.9% |
5 Years | 3.06 | 5.82 | 1.70 | 4.20 | 240,854 | 1.68 | 54.9% |
Stereotaxis Description
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is bifurcated into 3 segments that are Systems, Disposables, service, and accessories, and Sublease, out of which the majority of revenue is generated from the Disposables, service and accessories segment. The company generates the majority of revenue from the United States. |